Mesalazine

Author:Prof. Dr. med. Peter Altmeyer

Last updated on: 05.02.2023

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).

Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Sulfonamide derivative.

Half-lifeThis section has been translated automatically.

0,5-2,4 h or 6-9 h (metabolites).

Pharmacodynamics (Effect)This section has been translated automatically.

Inhibitor of prostaglandin and leukotriene synthesis, anti-inflammatory and immunosuppressive.

IndicationThis section has been translated automatically.

Chronic inflammatory bowel diseases, aphthae (topical application)

Dosage and method of useThis section has been translated automatically.

Tbl.: 3-4 times/day 500-1000 mg/day p.o.
Clysmes: 1 time per day before bedtime give the contents of 1 enema bottle as an enema into the intestine.
Rectal foam: 1 time per day before bedtime 2 sprays (= 10 g foam) into the intestine.

Standard concentrationThis section has been translated automatically.

Rectal foam: 20%.

PreparationsThis section has been translated automatically.

^{Claversal®500}mg, ^Salofalk® 500 mg, ^Pentasa® 500 mg; 1000 mg

Authors

Last updated on: 05.02.2023

Author: Prof. Dr. med. Peter Altmeyer